AstraZeneca UK Limited has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that it is recalling one batch of Bricanyl Injection 0.5 mg/ml solution for injection or infusion as a precautionary measure due to out of specification results for a routinely tested known impurity during stability testing.
Further information including the affected batch number, a brief description of the problem and advice for healthcare professionals can be found on the MHRA website.
Want the latest pharmacy news and updates straight to your inbox?
Sign up to our regular newsletter for the latest guidance, news, events and CPD opportunities.
Sign Up
Become an RPS Member today and save up to £26 by choosing annual Direct DebitOR spread the cost by switching to monthly payments.
RPS membership is better value than ever in 2024 - join today!
BECOME A MEMBER TODAY